Oniria Therapeutics
Biotechnology ResearchView the employees at
Oniria Therapeutics-
Tuo Chen Research Chemist
-
Greater Barcelona Metropolitan Area
-
Rising Star
Iris María Marcote Corral Técnico de laboratorio en Vall d'Hebron Institute of Oncology (VHIO)-
Greater Barcelona Metropolitan Area
-
Rising Star
David Aguilar Recarte, PhD Research Scientist at Oniria Therapeutics | PhD in Biomedicine | Biotechnologist-
Barcelona, Catalonia, Spain
-
Rising Star
Elsa Martínez Arce, Ph.D. Research Scientist-
Greater Barcelona Metropolitan Area
-
Rising Star
Natalia Ricco Innovation Manager at Oniria Therapeutics-
Montcada, Catalonia, Spain
-
Top 10%
Overview
A shift in cancer treatment methodology makes a world of difference. Oniria Therapeutics is a spin-off from Vall d'Hebron Institute of Oncology (VHIO), the University of Barcelona (UB) and the Catalan Institution for Research and Advanced Studies (ICREA). Oniria Therapeutics is a biotech company focused on the development of first-in-class drugs in the field of precision oncology. It develops therapies to modulate and eliminate dormant tumor cells as a novel targeted strategy to overcome their persistence. Our flagship product allosterically activates TET2, a master epigenetic enzyme.
-